Nivolumab and BO-112 Before Surgery for the Treatment of Resectable Soft Tissue Sarcoma
Conditions:   Leiomyosarcoma;   Myxofibrosarcoma;   Resectable Dedifferentiated Liposarcoma;   Resectable Soft Tissue Sarcoma;   Resectable Undifferentiated Pleomorphic Sarcoma;   Soft Tissue Fibrosarcoma;   Spindle Cell Sarcoma;   Stage I Retroperitoneal Sarcoma American Joint Committee on Cancer (AJCC) v8;   Stage I Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8;   Stage IA Retroperitoneal Sarcoma AJCC v8;   Stage IA Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8;...
Source: ClinicalTrials.gov - June 9, 2020 Category: Research Source Type: clinical trials

Preoperative Hypofractionated Radiotherapy With Hyperthermia in Primary Marginally Unresectable or Marginally Resectable Soft Tissue Sarcomas
Conditions:   Sarcoma;   Alveolar Soft Part Sarcoma;   Clear Cell Sarcoma;   Malignant Peripheral Nerve Sheath Tumors;   Myxoid Liposarcoma;   Liposarcoma, Dedifferentiated;   Synovial Sarcoma;   Leiomyosarcoma;   Undifferentiated Pleomorphic Sarcoma;   Fibrosarcoma;   Pleomorphic Rha bdomyosarcoma Interventions:   Radiation: Hypofractionated radiotherapy;   Other: Hyperthermia Sponsor:   Maria Sklodowska-Curie Institute - Oncology Center Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 18, 2019 Category: Research Source Type: clinical trials

Multimodal Immune Characterization of RAre Soft Tissue Sarcoma - MIRAS Project From SARRA (SARcome RAre) Project of the French Sarcoma Group
Conditions:   Soft Tissue Sarcoma;   Clear Cell Sarcoma;   Epithelioid Sarcoma;   Perivascular Epithelioid Cell Neoplasms;   Desmoplastic Small Round Cell Tumor;   Solitary Fibrous Tumors;   Alveolar Soft Part Sarcoma;   Epithelioid Hemangioendothelioma;   Low Grade Fibromyxoid Sa rcoma;   Sclerosing Epithelioid Fibrosarcoma Intervention:   Other: Patient with Soft Tissue Sarcoma Sponsor:   Institut Claudius Regaud N...
Source: ClinicalTrials.gov - May 30, 2019 Category: Research Source Type: clinical trials

A Study of Oral LOXO-292 in Pediatric Patients With Advanced Solid or Primary Central Nervous System Tumors
Conditions:   Medullary Thyroid Cancer;   Infantile Myofibromatosis;   Infantile Fibrosarcoma;   Papillary Thyroid Cancer;   Soft Tissue Sarcoma Intervention:   Drug: LOXO-292 Sponsor:   Loxo Oncology, Inc. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 2, 2019 Category: Research Source Type: clinical trials

Larotrectinib in Treating Patients With Previously Untreated TRK Fusion Solid Tumors and TRK Fusion Relapsed Acute Leukemia
Conditions:   Blasts 5 Percent or More of Bone Marrow Nucleated Cells;   Central Nervous System Neoplasm;   ETV6 Gene Rearrangement;   Infantile Fibrosarcoma;   NTRK1 Fusion Positive;   NTRK1 Gene Rearrangement;   NTRK2 Fusion Positive;   NTRK2 Gene Rearrangement;   NTRK3 Fusion Positi ve;   NTRK3 Gene Rearrangement;   Recurrent Acute Leukemia;   Refractory Acute Leukemia;   Solid Neoplasm Intervention:   Drug: Larotrectinib Sponsors: &...
Source: ClinicalTrials.gov - February 8, 2019 Category: Research Source Type: clinical trials